Inventor · disambiguated record
Isao Ooi
Also filed as: OOI ISAO
7 granted patents·5 pending applications·6 citations·filing 2016–2024
75Inventor score
Files withNIPPON CHEMIPHAR CO12
Top patents by PatentIndex Score
12 records- 0189US12109209B2Use of morphinan derivatives for treatment of opioid delta receptor agonist-related diseaseNIPPON CHEMIPHAR CO·Filed 2022·Granted Oct 8, 2024·1 cites·9 claims
- 0282US10442802B2Morphinan derivativeNIPPON CHEMIPHAR CO·Filed 2016·Granted Oct 15, 2019·4 cites·83 claims
- 0380US11633392B2Use of morphinan derivative for therapeutic treatment of opioid delta receptor agonist-related diseaseNIPPON CHEMIPHAR CO·Filed 2017·Granted Apr 25, 2023·1 cites·14 claims
- 0476US2024374583A1Use of morphinan derivatives for treatment of opioid delta receptor agonist-related diseaseNIPPON CHEMIPHAR CO·Filed 2024·Application pending·0 cites
- 0576US2023159530A1Morphinan derivativeNIPPON CHEMIPHAR CO·Filed 2023·Application pending·0 cites
- 0668US10995092B2Morphinan derivativeNIPPON CHEMIPHAR CO·Filed 2019·Granted May 4, 2021·0 cites·1 claims
- 0767US11643411B2Morphinan derivativeNIPPON CHEMIPHAR CO·Filed 2020·Granted May 9, 2023·0 cites·20 claims
- 0847US2022226299A1Use of t-type calcium channel blocker for treating pruritusNIPPON CHEMIPHAR CO·Filed 2020·Application pending·0 cites
- 0943US2022363667A1T-type calcium channel blockerNIPPON CHEMIPHAR CO·Filed 2019·Application pending·0 cites
- 1042US11370761B2Voltage-dependent T-type calcium channel inhibitorNIPPON CHEMIPHAR CO·Filed 2018·Granted Jun 28, 2022·0 cites·22 claims
- 1140US11420944B2Voltage-dependent t-type calcium channel blockerNIPPON CHEMIPHAR CO·Filed 2017·Granted Aug 23, 2022·0 cites·50 claims
- 1238US2021371422A1Morphinan derivativeNIPPON CHEMIPHAR CO·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →